RHOU and breast cancer: To assess the functional role of RHOU in this context we analyzed the highly aggressive basal-like breast cancer cell line MDA-MB-231, whose motility and invasivity have been shown to require the expression of the non-canonical WNT5a and WNT5b ligands [11,33].